Search consultations


Dihydrocodeine - Review of risks and benefits

NZNO warmly invites you to provide feedback on a review of the risks and benefits of dihydrocodeine.

This forms part of Medsafe and the Medicines Adverse Reactions Committee (MARC)’s review of the risks of misuse, abuse and dependence with opioids in New Zealand. 

Further information is available here.

Please send feedback to by 17 September 2021.


Notify me when this page changes

Enter your email address below to receive alerts when this page is updated.

Sign up below to receive an email when we update this page

Enter the code shown above in the box below.